{"id":"incabotulinumtoxina","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or bruising"},{"rate":null,"effect":"Muscle weakness"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Flu-like symptoms"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The drug cleaves SNARE proteins required for acetylcholine vesicle fusion and release at motor nerve terminals. This results in temporary denervation and muscle relaxation, lasting several months. It is used therapeutically to reduce muscle hyperactivity and spasticity in various neurological conditions.","oneSentence":"IncabotulinumtoxinA is a botulinum toxin type A that blocks acetylcholine release at the neuromuscular junction, causing temporary muscle paralysis.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:48:30.699Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Muscle spasticity associated with multiple sclerosis"},{"name":"Cervical dystonia"},{"name":"Blepharospasm"},{"name":"Hemifacial spasm"}]},"trialDetails":[{"nctId":"NCT01968902","phase":"PHASE4","title":"Safety of Xeomin for Lower Limb Spasticity in Multiple Sclerosis Patients","status":"COMPLETED","sponsor":"Multiple Sclerosis Center of Northeastern New York","startDate":"2013-11","conditions":"Muscle Spasticity, Multiple Sclerosis","enrollment":27}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Xeomin®"],"phase":"marketed","status":"active","brandName":"incabotulinumtoxinA","genericName":"incabotulinumtoxinA","companyName":"Multiple Sclerosis Center of Northeastern New York","companyId":"multiple-sclerosis-center-of-northeastern-new-york","modality":"Biologic","firstApprovalDate":"","aiSummary":"IncabotulinumtoxinA is a botulinum toxin type A that blocks acetylcholine release at the neuromuscular junction, causing temporary muscle paralysis. Used for Muscle spasticity associated with multiple sclerosis, Cervical dystonia, Blepharospasm.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}